# A Study Comparing the Pharmacokinetic Similarity of MB09 and EU/US-Sourced Xgeva

> **NCT05299073** · PHASE1 · COMPLETED · sponsor: **mAbxience Research S.L.** · enrollment: 257 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** MB09
- **DRUG:** US-sourced Xgeva
- **DRUG:** EU-sourced Xgeva

## Key facts

- **NCT ID:** NCT05299073
- **Lead sponsor:** mAbxience Research S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-01
- **Primary completion:** 2023-03-18
- **Final completion:** 2023-03-18
- **Target enrollment:** 257 (ACTUAL)
- **Last updated:** 2025-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05299073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05299073, "A Study Comparing the Pharmacokinetic Similarity of MB09 and EU/US-Sourced Xgeva". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05299073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*